LINC00888

Across TCGA pan-cancer cohorts, LINC00888 RNA is linked to patient survival in 27 of 34 cancer types, making it the most broadly survival-associated LINC00888 data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher LINC00888 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC00888 expression acts as an unfavorable survival marker, although some lineages such as UVM and LGG show a favorable association.

STAD, LUAD, and HNSC are the cancer types where LINC00888 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Tertile	All	0.388	0.774	<.001	82	view →
LUAD	DFS	Tertile	III,IV	0.358	0.800	.001	73	view →
HNSC	DFS	Median	All	0.521	0.682	<.001	71	view →
UVM	OS	Tertile	All	0.955	0.566	.001	56	view →
KICH	OS	Median	III,IV	0.490	1.000	.007	54	view →
MESO	OS	Quartile	All	0.170	0.438	.006	41	view →
COAD	DFS	Tertile	All	0.682	0.834	.019	33	view →
CESC	DFS	Quartile	All	0.736	0.872	.008	28	view →
BLCA	DFS	Quartile	IV	0.108	0.358	.011	26	view →
LGG	OS	Tertile	All	0.929	0.850	.001	25	view →
UCEC	DFS	Median	All	0.801	0.871	.008	20	view →
LIHC	OS	Tertile	III,IV	0.389	0.752	.004	20	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 27 lineages.

LINC00888–STAD (OS)

Open the STAD breakdown →